chr16-58515941-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001160305.4(SETD6):c.178C>T(p.Pro60Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000071 in 1,521,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001160305.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SETD6 | NM_001160305.4 | c.178C>T | p.Pro60Ser | missense_variant | 2/8 | ENST00000219315.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SETD6 | ENST00000219315.9 | c.178C>T | p.Pro60Ser | missense_variant | 2/8 | 1 | NM_001160305.4 |
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151756Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000600 AC: 7AN: 116756Hom.: 0 AF XY: 0.0000920 AC XY: 6AN XY: 65212
GnomAD4 exome AF: 0.0000672 AC: 92AN: 1369346Hom.: 0 Cov.: 32 AF XY: 0.0000621 AC XY: 42AN XY: 676368
GnomAD4 genome AF: 0.000105 AC: 16AN: 151868Hom.: 0 Cov.: 33 AF XY: 0.0000674 AC XY: 5AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 20, 2023 | The c.178C>T (p.P60S) alteration is located in exon 2 (coding exon 2) of the SETD6 gene. This alteration results from a C to T substitution at nucleotide position 178, causing the proline (P) at amino acid position 60 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at